U.S. drugmaker Clovis Oncology (CLVS.O) said on Wednesday it was likely to file for bankruptcy "in the very near term", as the company struggles to sell its cancer drug Rubraca. Sales of Rubraca, Clovis's only approved drug, have been hit in recent years by intensifying competition from rival ovarian cancer treatments, and partly by lower cancer diagnoses during the COVID-related lockdowns.
Irondequoit, N.Y. — The closure of a Walgreens in Rochester's 19th Ward has created a pharmacy desert for neighbors, and customers of other pharmacies across the state could face similar challenges.
"What we found was that rosuvastatin lowered LDL cholesterol by almost 38% and that was vastly superior to placebo and any of the six supplements studied in the trial," study author Luke Laffin, M.D. of the Cleveland Clinic's Heart, Vascular & Thoracic Institute told NPR.
(Reuters) - Teva Pharmaceuticals will pay up to $4.2 billion in the United States to settle claims related to its role in fueling the country's opioid crisis, New York Attorney General Letitia James said on Thursday.
